<qa>  What is the name of the vaccine that will be followed for one year?Participants in this study will receive the PolyEnv1 HIV vaccine and will be followed for one year. Laboratory tests will be performed at 10 study visits to monitor the participants immunologic response and assess the safety of the vaccine. Patients will also have numerous HIV tests throughout the study period. 